
Kirsten Ellizabeth Lyke MD
Associate Professor, Medicine, University of Maryland School of Medicine
Join to view full profile
22 S Greene StBaltimore, MD 21201
Phone+1 410-328-5793
Fax+1 410-328-0248
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 8 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Kirsten Lyke, MD is an infectious disease specialist in Baltimore, Maryland. She is currently licensed to practice medicine in Maryland and Arizona. She is affiliated with University of Maryland Medical Center and is an Associate Professor at University of Maryland School of Medicine.
Education & Training
Johns Hopkins UniversityFellowship, Infectious Disease, 1998 - 2001
Duke University HospitalResidency, Internal Medicine, 1992 - 1995
Georgetown University School of MedicineClass of 1992
Certifications & Licensure
MD State Medical License 1998 - 2026
AZ State Medical License 1996 - 1999
American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 3 citationsWhole-genome sieve analysis: Identification of protective malaria antigens by leveraging allele-specific vaccine efficacy.Ryan Scalsky, Ankit Dwivedi, Thomas C Stabler, Gillian Mbambo, Amed Ouattara
Vaccine. 2025-03-19 - 1 citationsImmune gene expression changes more during a malaria transmission season than between consecutive seasons.Kieran Tebben, Salif Yirampo, Drissa Coulibaly, Abdoulaye K Koné, Matthew B Laurens
Microbiology Spectrum. 2024-10-03 - 2 citationsChildren with hemoglobin C or S trait have low serologic responses to a subset of malaria variant surface antigens.Rachel D Bailey, Jonathan G Lawton, Amadou Niangaly, Emily M Stucke, Jason A Bailey
The Journal of Infection. 2024-10-01
Press Mentions
HMN 2025: How New Monoclonal Antibody Prevents Malaria Infection in Early Clinical TrialOctober 28th, 2025
Would You Get Sick in the Name of Science?January 28th, 2025
Building a Biomedical Research Enterprise That Leads to More Equity and Healthier LivesOctober 28th, 2024









